390
Views
1
CrossRef citations to date
0
Altmetric
Review

Practical implications for nurses caring for patients being treated for osteoporosis

&
Pages 19-33 | Published online: 13 May 2014

References

  • National Institutes of Health Osteoporosis and Related Bone Diseases National Resource Center. Osteoporosis overview. January, 2012. Available from: http://www.niams.nih.gov/Health_Info/Bone/Osteoporosis/overview.asp. Accessed February 4, 2014.
  • National Institutes of Health Osteoporosis and Related Bone Diseases National Resource Center. Osteoporosis prevention, diagnosis, and therapy. NIH Consensus Statement 2000. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11176917. Accessed February 4, 2014.
  • National Institutes of Health Osteoporosis and Related Bone Diseases National Resource Center. Juvenile osteoporosis. January, 2012. Available from: http://www.niams.nih.gov/Health_Info/Bone/Bone_Health/Juvenile/juvenile_osteoporosis.asp. Accessed February 4, 2014.
  • Bianchi ML. Osteoporosis in children and adolescents. Bone. 2007;41:486–495.
  • World Health Organization. Assessment of osteoporosis at the primary health care level. Summary Report of a WHO Scientific Group. Geneva, Switzerland; World Health Organization; 2007. Available from: www.who.int/chp/topics/rheumatic/. Accessed February 4, 2014.
  • Premaor MO, Compston JE. Testing for secondary causes of osteoporosis. BMJ. 2010;341:c6959.
  • Hofbauer LC, Hamann C, Ebeling PR. Approach to the patient with secondary osteoporosis. Eur J Endocrinol. 2010;162:1009–1020.
  • National Osteoporosis Foundation. Clinician’s guide to prevention and treatment of osteoporosis. Washington, DC, USA: National Osteoporosis Foundation. 2013. Available from: http://nof.org/hcp/clinicians-guide. Accessed February 4, 2014.
  • Bianchi ML. Causes of secondary pediatric osteoporosis. Pediatr Endocrinol Rev. 2013;10 Suppl 2:424–436.
  • International Osteoporosis Foundation. Bone care for the postmenopausal woman. Nyon, Switzerland: International Osteoporosis Foundation; 2013. Available from: http://www.iofbonehealth.org/data-publications/reports/bone-care-postmenopausal-woman. Accessed February 4, 2014.
  • Kanis JA, Odén A, McCloskey EV, Johansson H, Wahl DA, Cooper C; IOF Working Group on Epidemiology and Quality of Life. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int. 2012;23:2239–2256.
  • Siris ES, Chen YT, Abbott TA, et al. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med. 2004;164:1108–1112.
  • National Institutes of Health Osteoporosis and Related Bone Diseases National Resource Center. Osteoporosis and Asian American women. Jan 2012. Available from: http://www.niams.nih.gov/Health_Info/Bone/Osteoporosis/Background/asian_american_women.asp. Accessed February 4, 2014.
  • American College of Obstetricians and Gynecologists. Committee on Practice Bulletins-Gynecology. Practice Bulletin #129. Osteoporosis. Obstet Gynecol. 2012;120:718–734.
  • Johnell O, Kanis J. Epidemiology of osteoporotic fractures. Osteoporos Int. 2005;16 Suppl 2:S3–S7.
  • Rao SS, Budhwar N, Ashfaque A. Osteoporosis in men. Am Fam Physician. 2010;82:503–508.
  • US Preventive Services Task Force. Screening for osteoporosis: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2011;154:356–364.
  • US Department of Health and Human Services. Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Office of the Surgeon General; 2004.
  • Licata A. Bone density vs bone quality: what’s a clinician to do? Cleve Clin J Med. 2009;76:331–336.
  • Seeman E, Delmas PD. Bone quality – the material and structural basis of bone strength and fragility. N Engl J Med. 2006;354:2250–2261.
  • Lerner UH. Osteoblasts, osteoclasts, and osteocytes: unveiling their intimate-associated responses to applied orthodontic forces. Semin Orthod. 2012;18:237–248.
  • Sandhu SK, Hampson G. The pathogenesis, diagnosis, investigation and management of osteoporosis. J Clin Pathol. 2011;64:1042–1050.
  • Davidge Pitts CJ, Kearns AE. Update on medications with adverse skeletal effects. Mayo Clin Proc. 2011;86:338–343.
  • Ström O, Borgstrom F, Kanis JA, et al. Osteoporosis: burden, health care provision and opportunities in the EU. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2011;6:59–155.
  • Florence R, Allen S, Benedict L, et al. Institute for Clinical Systems Improvement. Diagnosis and Treatment of Osteoporosis. Updated Jul 2013. Available from: https://www.icsi.org/_asset/vnw0c3/Osteo-Interactive0711.pdf. Accessed February 14, 2014.
  • Adachi JD, Adami S, Gehlbach S, et al. Impact of prevalent fractures on quality of life: baseline results from the Global Longitudinal Study of Osteoporosis in Women. Mayo Clin Proc. 2010;85:806–813.
  • Rizzoli R, Brandi ML, Dreinhöfer KE, Thomas T, Wahl DA, Cooper C. The gaps between patient and physician understanding of the emotional and physical impact of osteoporosis. Arch Osteoporos. 2010;5:145–153.
  • Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res. 2007;22:465–475.
  • Cauley JA. Public health impact of osteoporosis. J Gerontol A Biol Sci. 2013;68:1243–1251.
  • Tosteson AN, Melton LJ 3rd, Dawson-Hughes B, et al; National Osteoporosis Foundation Guide Committee. Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int. 2008;19:437–447.
  • Siris ES, Modi A, Tang J, Gandhi S, Sen S. Substantial under-treatment among women diagnosed with osteoporosis in a US managed-care population: a retrospective analysis. Curr Med Res Opin. 2014;30:123–130.
  • Greenspan SL, Wyman A, Hooven FH, et al. Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal women. J Am Geriatr Soc. 2012;60:455–461.
  • Port L, Center J, Briffa NK, Nguyen T, Cumming R, Eisman J. Osteoporotic fracture: missed opportunity for intervention. Osteoporos Int. 3003;14:780–784.
  • Sosa M, Gonzalez-Padila E. Promising developments in osteoporosis treatment. Int J Clin Rheumatol. 2011;6:325–332.
  • Hans DB, Kanis JA, Baim S, et al; FRAX® Position Development Conference Members. Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®. Executive Summary of the 2010 Position Development Conference on Interpretation and use of FRAX® in clinical practice. J Clin Densitom. 2011;14:171–180.
  • Kanis JA, Hans D, Cooper C, et al. Task Force of the FRAX Initiative. Interpretation and use of FRAX in clinical practice. Osteoporos Int. 2011;22:2395–2411.
  • Unnanuntana A, Gladnick BP, Donnelly E, Lane JM. The assessment of fracture risk. J Bone Joint Surg Am. 2010;92:743–753.
  • Hippisley-Cox J, Coupland C. Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study. BMJ. 2012;344:e3427.
  • Ettinger B, Blackwell T, Hoffman AR, Ensrud KE, Orwoll ES; Osteoporotic Fracture in Men (MrOS) Research Group. Validation of FRC, a fracture risk assessment tool, in a cohort of older men: the Osteoporotic Fractures in Men (MrOS) Study. J Clin Densitom. 2012;15:334–342.
  • Shepherd AJ, Cass AR, Carlson CA, Ray L. Development and internal validation of the male osteoporosis risk estimation score. Ann Fam Med. 2007;5:540–546.
  • National Guideline Clearinghouse. Guideline synthesis: Screening and risk assessment for osteoporosis. In: National Guideline Clearinghouse. Rockville, MD, USA: Agency for Healthcare Research and Quality; 2008. Available from: http://www.guideline.gov/syntheses/synthesis.aspx?id=38658. Accessed February 14, 2014.
  • Ensrud KE, Ewing SK, Taylor BC, et al. Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med. 2008;168:382–389.
  • Dempster DW. Osteoporosis and the burden of osteoporosis-related fractures. Am J Manag Care. 2011;117 Suppl 6:S164–S169.
  • National Institutes of Health Osteoporosis and Related Bone Diseases National Resource Center. Bone Mass Measurement: What the numbers mean. Jan 2012. Available from: http://www.niams.nih.gov/Health_Info/Bone/Bone_Health/bone_mass_measure.asp. Accessed February 14, 2014.
  • Wall M, Lohfeld L, Giangregorio L, et al. Fracture risk assessment in long-term care: a survey of long-term care physicians. BMC Geriatr. 2013;13:109.
  • Mitchell PJ. Fracture Liaison Services: a systematic approach to secondary fracture prevention. Osteoporosis Review. 2009;17:14–16.
  • Giles M, Van Der Kallen J, Parker V, et al. A team approach: implementing a model of care for preventing osteoporosis related fractures. Osteoporos Int. 2011;22:2321–2328.
  • Eisman JA, Bogoch ER, Dell R, et al. Making the first fracture the last fracture: ASBMR Task Force report on secondary fracture prevention. J Bone Miner Res. 2012;27:1–8.
  • Ganda J, Puech M, Chen JS, et al. Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis. Osteoporos Int. 2013;24:393–406.
  • Nahm ES, Barker B, Resnick B, Covington B, Magaziner J, Brennan PF. Effects of a social cognitive theory-based hip fracture prevention web site for older adults. Comput Inform Nurs. 2010;28:371–379.
  • Qi BB, Resnick B, Smeltzer SC, Bausell B. Self-efficacy program to prevent osteoporosis among Chinese immigrants: a randomized controlled trial. Nurs Res. 2011;60:393–404.
  • Ryan P, Schlidt A, Ryan C. The impact of osteoporosis prevention programs on calcium intake: a systematic review. Osteoporos Int. 2013; 24:1791–1801.
  • Sujic R, Gignac MA, Cockerill R. A review of patient-centred post-fracture interventions in the context of theories of health behaviour change. Osteoporos Int. 2011;22:2213–2224.
  • Lau AN, Ioannidis G, Potts Y, et al. What are the beliefs, attitudes and practices of front-line staff in long-term care (LTC) facilities related to osteoporosis awareness, management and fracture prevention? BMC Geriatr. 2010;10:73.
  • Lee LY, Lai EK. Osteoporosis in older Chinese men: knowledge and health beliefs. J Clin Nurs. 2006;15:353–355.
  • Sharts-Hopko NC, Sullivan MP. Beliefs, perceptions, and practices related to osteoporosis risk reduction among women with multiple sclerosis. Rehabil Nurs. 2002;27:232–236.
  • Smeltzer SC, Zimmerman V, Capriotti T. Osteoporosis risk and low bone mineral density in women with physical disabilities. Arch Phys Med Rehabil. 2005;86:582–586.
  • Endicott RD. Knowledge, health beliefs, and self-efficacy regarding osteoporosis in perimenopausal women. J Osteoporos. 2013;2013:853531.
  • Twiss JJ, Gross GJ, Waltman NL, Ott CD, Lindsey AM. Health behaviors in breast cancer survivors experiencing bone loss. J Am Acad Nurse Pract. 2006;18:471–481.
  • Chang SF. Knowledge, health beliefs and health-related behaviours of first-degree relatives of women suffering from osteoporosis in Taiwan: a questionnaire survey. J Clin Nurs. 2008;17:1280–1286.
  • Chang SF, Yang RS, Chung UL, Chen CM, Cheng MH. Perception of risk factors and DXA T score among at-risk females of osteoporosis. J Clin Nurs. 2010;19:1795–1802.
  • Sandison R, Gray M, Reid DM. Lifestyle factors for promoting bone health in older women. J Adv Nurs. 2004;45:603–610.
  • Besser SJ, Anderson JE, Weinman J. How do osteoporosis patients perceive their illness and treatment? Implications for clinical practice. Arch Osteoporos. 2012;7:115–124.
  • Brennan SL, Pasco JA, Urquhart DM, Oldenburg B, Hanna F, Wluka AE. The association between socioeconomic status and osteoporotic fracture in population-based adults: a systematic review. Osteoporos Int. 2009;20:1487–1497.
  • Navarro MC, Sosa M, Saavedra P, et al. Poverty is a risk factor for osteoporotic fractures. Osteoporos Int. 2009;20:393–398.
  • Drake MT, Khosla S. Male osteoporosis. Endocrinol Metab Clin North Am. 2012;41:629–641.
  • Templeton KJ. Commentary on: Male and non-English-speaking patients with fracture have poorer knowledge of osteoporosis. J Bone Joint Surg Am. 2011;20;93:e43.
  • Amre H, Safadi R, Jarrah S, Al-Amer R, Froelicher ES. Jordanian nursing students’ knowledge of osteoporosis. Int J Nurs Pract. 2008;14: 228–236.
  • Zhang YP, Li XM, Wang DL, Guo XY, Guo X. Evaluation of educational program on osteoporosis awareness and prevention among nurse students in China. Nurs Health Sci. 2012;14:74–80.
  • Lai PS, Chua SS, Chan SP. Impact of pharmaceutical care on knowledge, quality of life and satisfaction of postmenopausal women with osteoporosis. Int J Clin Pharm. 2013;35:629–637.
  • Solomon DH, Gleeson T, Iversen M, et al. A blinded randomized controlled trial of motivational interviewing to improve adherence with osteoporosis medications: design of the OPTIMA trial. Osteoporos Int. 2010;21:137–144.
  • Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;2:CD000011.
  • Gleeson T, Iversen MD, Avorn J, et al. Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review. Osteoporos Int. 2009;20:2127–2134.
  • Shanthi Johnson CS, McLeod W, Kennedy L, McLeod K. Osteoporosis health beliefs among younger and older men and women. Health Educ Behav. 2008;35:721–733.
  • McLeod KM, Johnson CS. A systematic review of osteoporosis health beliefs in adult men and women. J Osteoporos. 2011;2011:197454.
  • Resnick B, Jenkins LS. Testing the reliability and validity of the self-efficacy for exercise scale. Nurs Res. 2000;49:154–159.
  • Resnick B, Gruber-Baldini AL, Galik E, et al. Changing the philosophy of care in long-term care: testing of the restorative care intervention. Gerontologist. 2009;49:175–184.
  • Resnick B, Wehren L, Orwig D. Reliability and validity of the self-efficacy and outcome expectations for osteoporosis medication adherence scales. Orthop Nurs. 2003;22:139–147.
  • Bhurosy T, Jeewon R. Effectiveness of a theory-driven nutritional education program in improving calcium intake among older Mauritian adults. Scientific World Journal. 2013;2013:750128.
  • Ha M, Hu J, Petrini MA, McCoy TP. The effects of an educational self efficacy intervention on osteoporosis prevention and diabetes self-management among adults with type 2 diabetes mellitus. Biol Res Nurs. January 10, 2014. [Epub ahead of print.]
  • Plawecki K, Chapman-Novakofski K. Effectiveness of community intervention in improving bone health behaviors in older adults. J Nutr Gerontol Geriatr. 2013;32:145–160.
  • Chan MF, Kwong WS, Zang YL, Wan PY. Evaluation of an osteoporosis prevention education programme for young adults. J Adv Nurs. 2007;57:270–285.
  • Chan MF, Ko CY, Day MC. The effectiveness of an osteoporosis prevention education programme for women in Hong Kong: a randomized controlled trial. J Clin Nurs. 2005;14:1112–1123.
  • Chan MF, Ko CY. Osteoporosis prevention education programme for women. J Adv Nurs. 2006;54:159–170.
  • Ryan P, Maierle D, Csuka ME, Thomson A, Szabo A. Computer-based intervention to enhance self-management of calcium and vitamin D in women. West J Nurs Res. 2013;35:986–1010.
  • Sedlak CA, Doheny MO, Jones SL. Osteoporosis education programs: changing knowledge and behaviors. Public Health Nurs. 2000;17:398–402.
  • Sedlak CA, Doheny MO, Estok PJ, Zeller RA, Winchell J. DXA, health beliefs, and osteoporosis prevention behaviors. J Aging Health. 2007;19:742–756.
  • Silverman S, Gold DT. Compliance and persistence with osteoporosis medications: a critical review of the literature. Rev Endocr Metab Disord. 2010;11:275–280.
  • Rizzoli R, Abraham C, Brandi ML. Nutrition and bone health: turning knowledge and beliefs into healthy behaviour. Curr Med Res Opin. 2014;30(1):131–141.
  • Dheny MO, Sedlak CA, Hall RJ, Estok PJ. Structural model for osteoporosis preventing behavior in men. Am J Mens Health. 2010;4: 334–343.
  • Mauck KF, Clarke BL. Diagnosis, screening, prevention, and treatment of osteoporosis. Mayo Clin Proc. 2006;81:662–672.
  • Pollycove R, Simon JA. Osteoporosis: screening and treatment in women. Clin Obstet Gynecol. 2012;55:681–691.
  • Lems WF, den Heijer M. Established and forthcoming drugs for the treatment of osteoporosis. Neth J Med. 2013;71(4):188–193.
  • Suresh E, Pazianas M, Abrahamsen B. Safety issues with bisphosphonate therapy for osteoporosis. Rheumatology (Oxford). 2014;53(1):19–31.
  • Chen HV. Bisphosphonate-associated osteonecrosis of the jaw: patient care considerations: overview for the orthopaedic nursing healthcare professional. Orthop Nurs. 2010;29:176–180.
  • Hodges LA, Connolly SM, Winter J, et al. Modulation of gastric pH by a buffered soluble effervescent formulation: a possible means of improving gastric tolerability of alendronate. Int J Pharm. 2012;432:57–62.
  • Sedghizadeh PP, Stanley K, Caligiuri M, Hofkes S, Lowry B, Shyler CF. Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: an institutional inquiry. J Am Dent Assoc. 2009;140:61–66.
  • Ragucci KR, Shrader SP. Osteoporosis treatment: an evidence-based approach. J Gerontol Nurs. 2011;37:17–22.
  • Boonen S, Adachi JD, Man Z, et al. Treatment with denosumab reduces the incidence of new vertebral and hip fractures in postmenopausal women at high risk. J Clin Endocrinol Metab. 2011;96:1727–1736.
  • Papapoulos S, Chapurlat R, Libanati C, et al. Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension. J Bone Miner Res. 2012;27:694–701.
  • Cummings SR, San Martin J, McClung MR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009;361:756–765.
  • Delmas PD, Genant HK, Crans GG, et al. Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone. 2003;33:522–532.
  • Vogel VG, Costantino JP, Wickerham DL, et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA. 2006;295:2727–2741.
  • Ljunggren Ö, Barrett A, Stoykov I, et al. Effective osteoporosis treatment with teriparatide is associated with enhanced quality of life in postmenopausal women with osteoporosis: the European Forsteo Observational Study. BMC Musculoskelet Disord. 2013;14:251.
  • Cranney A, Tugwell P, Zytaruk N, et al. Meta-analyses of therapies for postmenopausal osteoporosis. VI. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis. Endocr Rev. 2002;23:540–551.
  • National Osteoporosis Foundation. FDA panel votes to remove long-used osteoporosis drug over cancer risk. March 13, 2013. Available from: http://nof.org/news/944. Accessed February 4, 2014.
  • Martyn-St James M, Carroll S. A meta-analysis of impact exercise on postmenopausal bone loss: the case for mixed loading exercise programmes. Br J Sports Med. 2009;43:898–908.
  • Martyn-St James M, Carroll S. Effects of different impact exercise modalities on bone mineral density in premenopausal women: a meta-analysis. J Bone Miner Metab. 2010;28:251–267.
  • de Kam D, Smulders E, Weerdesteyn V, Smits-Engelsman BC. Exercise interventions to reduce fall-related fractures and their risk factors in individuals with low bone density: a systematic review of randomized controlled trials. Osteoporos Int. 2009;20:2111–2125.
  • Sinaki M, Pfeifer M, Preisinger E, et al. The role of exercise in the treatment of osteoporosis. Curr Osteoporos Rep. 2010;8:138–144.
  • Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ. 2009;339:b3692.
  • Smith ML, Ory MG, Ahn S, Bazzarre TL, Resnick B. Older adults’ participation in a community-based falls prevention exercise program: relationships between the EASY tool, program attendance, and health outcomes. Gerontologist. 2011;51:809–821.
  • Institute of Medicine. Consensus report: Dietary reference intakes for calcium and vitamin D. November 30, 2010. Available from: http://www.iom.edu/Reports/2010/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D.aspx. Accessed February 14, 2014.
  • Gammage KL, Francoeur C, Mack DE, Klentrou P. Osteoporosis health beliefs and knowledge in college students: the role of dietary retraining. Eat Behav. 2009;10:65–67.
  • Gammage KL, Klentrou P. Predicting osteoporosis prevention behaviors: health beliefs and knowledge. Am J Health Behav. 2011;35:371–382.
  • Francis KL, Matthews BL, Van Mechelen W, Bennell KL, Osborne RH. Effectiveness of a community-based osteoporosis education and self-management course: a wait list controlled trial. Osteoporos Int. 2009;20:1563–1570.
  • Laslett LL, Lynch J, Sullivan TR, McNeil JD. Osteoporosis education improves osteoporosis knowledge and dietary calcium: comparison of a 4-week and a one-session education course. Int J Rheum Dis. 2011;14:239–247.
  • Drieling RL, Ma J, Thiyagarajan S, Stafford RS. An Internet-based osteoporotic fracture risk program: effect on knowledge, attitudes, and behaviors. J Womens Health (Larchmt). 2011;20:1895–1907.
  • Gaines JM, Marx KA. Older men’s knowledge about osteoporosis and educational interventions to increase osteoporosis knowledge in older men: a systematic review. Maturitas. 2011;68:5–12.
  • Babatunde OT, Himburg SP, Newman FL, Campa A, Dixon Z. Theory-driven intervention improves calcium intake, osteoporosis knowledge, and self-efficacy in community-dwelling older Black adults. J Nutr Educ Behav. 2011;43:434–440.
  • Darling AL, Millward DJ, Torgerson DJ, Hewitt CE, Lanham-New SA. Dietary protein and bone health: a systematic review and meta-analysis. Am J Clin Nutr. 2009;90:1674–1692.
  • Kanis JA, McCloskey EV, Johansson H, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2013;24:23–57.